Instant Access

Implementation of Risk Evaluation and Mitigation Strategy (REMS) - What do you need to do now?

4411
Duration60 Minutes
Gwendolyn Wise-Blackman
Instructor

Gwendolyn Wise-Blackman

View profile

Attendees will receive knowledge on important and essential requirements related to Risk Management for potential pharmaceutical adverse effects. This webinar will provide basic understanding of requirements for REMS and steps to consider for implementation.

Course Objectives:

• Risk Management and Risk Minimization Action Plans 2005
• Consequences of FDAAA 2007
• Understanding the impact
• Assessing the potential need for a REMS
• Responding to a requirement for a REMS
• Voluntary submission of a REMS
• Implementing a REMS

Background:

Pharmaceutical and biologic products often have untoward effects in patient populations. The FDA requires that a plan be in place (Risk Evaluation and Mitigation Strategy or REMS) to assure continued safety of a drug. The purpose of these plans is to provide information to providers, pharmacies, and patients about the risks associated with certain drugs deemed to need REMS. Effective REMS addresses all potential issues, communicates the plan, has good implementation, and has follow-up to assess the impact of the plan.

Why Should You Attend:

Pharmaceutical and biologic products may have adverse effects. This can be observed either in general or in specific patient populations. Adverse effects may be related to class and structure and may be observed after approval of the drug. Strategies must be in place if a pharmaceutical or biologic product is deemed to likely have or is observed to exhibit a harmful response in addition to the health benefit. To assure public safety, the FDA requires implementation of a plan designed to mitigate the risk. These plans are developed as part of a risk evaluation and mitigation strategy (REMS).

Course Outline:

• FDAAA and risk management
• Assessing the need for REMS
• REMS and adverse effects
• Contributing factors
• Preparing a REMS
• Communication
• Submission timeline
• Implementation
• Patient registration

What You Get:

•  Training Reference Materials
•  Live Q&A with our Expert
•  Participation Certificate
•  Access to Signup Community (Optional)
•  Reward Points

Who Will Benefit:

• Regulatory Affairs
• Compliance
• Clinical Research Administrators
• Study Sponsors
• Legal
• Senior Management (production, supply chain and operations)
• Pharmacovigilance
• Medical Affairs
• Clinical Development
• Clinical Affairs
• Clinical Research
• Pharmacists
• Biostatisticians

Please reach us at 1-888-844-8963 for any further assistance or if you wish to register

100% MONEY BACK GUARANTEED

Refund / Cancellation policy

Get In Touch

Subject : Implementation of Risk Evaluation and Mitigation Strategy (REMS) - What do you need to do now?


Similar Trainings

Microbiological and Business Risk of not Testing Raw Materials for Microbial Presence
Life Sciences Pharmaceutical | Biotechnology | Clinical | Laboratory
Get Instant Access 60 Minutes
View Program
Bioavailability and Bioequivalence Studies submitted in NDAs and INDs
Life Sciences Pharmaceutical | Biotechnology | Clinical | Laboratory
Get Instant Access 90 Minutes
View Program
Veterinary Feed Directive (VFD) Final Rule – What you need to know?
Life Sciences Pharmaceutical | Biotechnology | Clinical | Laboratory
Get Instant Access 60 Minutes
View Program
Packaging and Labeling for Commercial and Clinical Products
Life Sciences Pharmaceutical | Biotechnology | Clinical | Laboratory
Get Instant Access 90 Minutes
View Program
Providing DMFs in eCTD format
Life Sciences Pharmaceutical | Biotechnology | Clinical | Laboratory
Get Instant Access 90 Minutes
View Program